Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Cyclospora parasite illnesses have affected 28 NC counties, sickened more than 200 people
Recommended
Back to school guide: Buses, lunches, key dates
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Innate Pharma SA
< Previous
1
2
3
Next >
Innate Pharma Files Its 2022 Universal Registration Document (Document d’enregistrement universel) and 2022 Annual Report on Form 20-F
April 06, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
April 03, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
March 23, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of March 1, 2023
March 20, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
March 16, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Provides Update on Silicon Valley Bank Exposure
March 13, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
February 21, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conferences
February 07, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
January 25, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Publication of Preclinical Data with a Trifunctional NK Cell Engager in Acute Myeloid Leukemia in Nature Biotechnology
January 16, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
December 19, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
SNY
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022
December 10, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
December 09, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
December 01, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Reports Third Quarter Financial Results
November 14, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update
November 07, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
November 04, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conferences
November 02, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma 2023 Financial Calendar
October 20, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides
September 23, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Reports First Half 2022 Financial Results and Business Update
September 15, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update
September 08, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
September 05, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conferences
August 23, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2022
August 08, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study
August 01, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conference
July 28, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Second Innate Pharma NK Cell Engager Selected by Sanofi as Drug Candidate for Development
July 21, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conference
June 23, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Innate Pharma to Participate in Upcoming Investor Conferences
May 11, 2022
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.